Merck & Co Inc (MRK)
101.87
-0.01
(-0.01%)
USD |
NYSE |
Nov 04, 16:00
101.68
-0.19
(-0.19%)
Pre-Market: 08:44
Merck Cash from Financing (Quarterly): 1.216B for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.216B |
| March 31, 2024 | -2.814B |
| December 31, 2023 | -2.245B |
| September 30, 2023 | -4.269B |
| June 30, 2023 | 3.758B |
| March 31, 2023 | -2.054B |
| December 31, 2022 | -1.554B |
| September 30, 2022 | -2.702B |
| June 30, 2022 | -1.777B |
| March 31, 2022 | -3.086B |
| December 31, 2021 | 5.207B |
| September 30, 2021 | -2.274B |
| June 30, 2021 | 1.758B |
| March 31, 2021 | -2.098B |
| December 31, 2020 | 1.372B |
| September 30, 2020 | -3.851B |
| June 30, 2020 | 1.137B |
| March 31, 2020 | -1.49B |
| December 31, 2019 | -2.011B |
| September 30, 2019 | -3.152B |
| June 30, 2019 | -2.084B |
| March 31, 2019 | -1.614B |
| December 31, 2018 | -5.566B |
| September 30, 2018 | -1.905B |
| June 30, 2018 | -2.967B |
| Date | Value |
|---|---|
| March 31, 2018 | -2.722B |
| December 31, 2017 | -5.785B |
| September 30, 2017 | 536.00M |
| June 30, 2017 | -6.218B |
| March 31, 2017 | 1.461B |
| December 31, 2016 | -1.977B |
| September 30, 2016 | -835.00M |
| June 30, 2016 | -3.366B |
| March 31, 2016 | -2.866B |
| December 31, 2015 | -2.406B |
| September 30, 2015 | -2.539B |
| June 30, 2015 | -5.597B |
| March 31, 2015 | 5.155B |
| December 31, 2014 | -9.772B |
| September 30, 2014 | 1.279B |
| June 30, 2014 | -8.369B |
| March 31, 2014 | 1.62B |
| December 31, 2013 | -2.624B |
| September 30, 2013 | -2.915B |
| June 30, 2013 | 970.00M |
| March 31, 2013 | -1.421B |
| December 31, 2012 | -1.218B |
| September 30, 2012 | -738.00M |
| June 30, 2012 | -586.00M |
| March 31, 2012 | -725.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-4.269B
Minimum
Sep 2023
5.207B
Maximum
Dec 2021
-935.63M
Average
-2.011B
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
| Amgen Inc | -3.651B |
| Johnson & Johnson | -9.882B |
| Eli Lilly and Co | 211.30M |
| Pfizer Inc | -2.459B |
| Moderna Inc | 34.00M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.637B |
| Cash from Investing (Quarterly) | -1.069B |
| Free Cash Flow | 13.15B |
| Free Cash Flow Per Share (Quarterly) | 1.905 |
| Free Cash Flow to Equity (Quarterly) | 1.277B |
| Free Cash Flow to Firm (Quarterly) | 5.065B |
| Free Cash Flow Yield | 5.08% |